Hydralazine Hydrochloride
NDC 70518-4064, Hydralazine Hydrochloride, tablet, from REMEDYREPACK INC..
- Product NDC
- 70518-4064
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040858
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4064 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDRALAZINE HYDROCHLORIDE25 mg/1
Pharmacologic classes
Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-4064-2 | 70518406402 | 180 TABLET in 1 BOTTLE, PLASTIC (70518-4064-2) |
| 70518-4064-3 | 70518406403 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-4064-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6c40d818-77a9-492c-b9b6-d8a0fe8d6736
Use it
Look up 70518-4064 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4064 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-4064. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.